Organogenesis Acquires NanoMatrix
Organogenesis Inc. said Monday the company has acquired NanoMatrix Inc. for an undisclosed amount.
Article
Regeneration Technologies, Tutogen Medical Merger Completed
Regeneration Technologies, Inc. and Tutogen Medical, Inc. have announced that the merger of the two companies is completed. The merger was approved by the shareholders of both Regeneration Technologies and Tutogen Medical at separate special shareholder meetings. The total value of the transaction is approximately $205 million.
Article
Stem Cell Therapy International Signs Memorandum of Intent to Merge With a Leading Umbilical Cord Stem Cell Company Histostem, Co., Ltd. of Korea
On February 27, 2008, Calvin Cao, CEO and President of Stem Cell Therapy International, Inc. and Dr. Han Hoon, CEO and President of Histostem, Co., Ltd., of Korea jointly announced the signing of a Memorandum of Understanding for their companies to merge subject to further discussions with respect to operational details and the signing of the definitive agreement.
Article
Living Cell Technologies and US- Based Barbara Davis Center to collaborate on Diabetes Clinical Trial Program
Living Cell Technologies Limited has announced that the Company has signed a term sheet with the Barbara Davis Center for Childhood Diabetes to establish a diabetes clinical trial program in Denver, Colorado.
Article
International Stem Cell Corporation’s Human Parthenogenetic Stem Cells to be used in Germany in the Development of Treatments for Neural Disease
The work will be headed by Dr. Albrecht Mueller of the University of Wuerzburg, Wuerzburg, Germany under a Material Transfer Agreement between International Stem Cell Corporation and the University of Wuerzburg.
Article
Advanced Cell Technology, Inc. Enters into License Agreement with Pharming Group N.V.
Advanced Cell Technology, Inc. has announced that it has entered into an agreement with Pharming Group N.V. giving Pharming an exclusive, global license to non-human use of certain patents associated with but not limited to oocyte activation patents held by Advanced Cell Technology.
Article
ThermoGenesis Subsidiary Vantus Announces Stem Cell Agreement With UC Davis Center For Equine Health
Under the agreement, the two organizations will conduct joint research and development of methods to enhance the collecting, processing and storing of stem cells from equine cord blood, bone marrow and placental tissue.
Article
ReachBio Partners with Axiogenesis to Distribute Novel Cell-Based Products in North America
The agreement gives ReachBio exclusive North American distribution rights to pure cardiomyocytes and other novel ES cell-derived products for drug discovery, toxicity testing, and R&D applications.
Article
Two Cord Blood Banks Opened to Public
Two human umbilical cord blood banks in the cities of Beijing and Tianjin have received the authorization from the Ministry of Health and opened to the public.
Article
U.S. Patent Office Upholds Key Human Embryonic Stem Cell Patent
Geron Corporation has announced that the U.S. Patent Office has upheld the validity of a key patent for human embryonic stem cells. The patent is assigned to the Wisconsin Alumni Foundation (“WARF”) and is one of three related patents challenged through reexamination proceedings.
Article
Americans for Cures Foundation Announces Michael J. Fox as Keynote Speaker at April Conference
Americans for Cures Foundation announces Michael J. Fox as a featured speaker at State of Stem Cell Advocacy 2008, this year’s leading conference for grassroots advocates supporting stem cell research.
Article
Osiris Therapeutics Strengthens Management Team
Osiris Therapeutics, Inc. has announced the addition Dr. Jeffry Lawrence, M.D. as Executive Medical Director and Dr. Jesus Soriano M.D., Ph.D. as Senior Director of Business Development.
Article
Stem Cell Company t2cure Appoints Dr Rueck Head of Clinical Operations
t2cure has announced that it has appointed Dr. Petra Rueck Head of Clinical Operations.
Article